Prescription patterns of analgesics in the last 3 months of life: a retrospective analysis of 10202 lung cancer patients.

ABSTRACT

BACKGROUND: To describe the prescription patterns of analgesics during the last 3 months of life in lung cancer and to determine the associated factors. METHODS: Data on lung cancer patients (N=10,202) who died during 2000-2008 were extracted from the General Practice Research Database (GPRD). This database records prescriptions of patients received from UK general practices (GP), but not those from non-GP routes. Prescription prevalences were estimated. The associated factors were investigated using log-binomial regression. RESULTS: The overall prescription prevalences were 50.4% (95% confidence interval (CI) 49.4-51.4%) for level 1 (e.g., paracetamol), 34.1% (95% CI 33.2-35.0%) for level 2 (weak opioids), and 55.5 % (95% CI 54.5-56.4%) for level 3 analgesics (strong opioids). Prescription prevalence of analgesics of all levels showed an increasing trend over the period 2000-2008 (annual increases range 1.1-1.5%) but a decreasing trend with age (average decrease per group range -5.8 to -1.8%). Patients in the older age groups were less likely to be prescribed level 3 analgesics than those in the younger age groups (PR('90+' vs '<50')=0.55 (95% CI 0.45-0.67); PR('80-89' vs '<50')=0.73 (95% CI 0.66-0.79); PR('70-79' vs '<50')=0.84 (95% CI 0.77-0.90)). CONCLUSION: Analgesics have been increasingly prescribed in lung cancer. However, analgesics, especially at level 3, were relatively under-prescribed to people older than 70 years, warranting further investigation.